Following development by GMMMG subgroups, we now seek comments on two drafts:
- Medicines Optimisation Guidance for Targeted Deprescribing, including NSAIDs, PPIs and propranolol. This consultation will run for two weeks and closes on Wednesday 29th July
- Commissioning statement for norethisterone 5mg tablets when used for postponement of menstruation for non-clinical purposes. This consultation will run for six weeks and closes at 5pm on Wednesday 26th August.
To take part in these or any other GMMMG consultations, visit the consultations page.